The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies

被引：2
|
作者：
Nath, Karthik [1 ]
Mailankody, Sham [1 ,2 ,3 ]
Usmani, Saad Z. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA
[3] Weill Cornell Med Coll, Dept Med, New York, NY USA
[4] Mem Sloan Kettering Cance, Adult Bone Marrow Transplant Serv, New York, NY USA
[5] 30 East 74th St,Room 20-228, New York, NY 10021 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
CAR T-cell therapy; Bispecific antibodies; Immunotherapeutic agents; Multiple myeloma; MULTIPLE-MYELOMA; MATURATION ANTIGEN; PLUS LENALIDOMIDE; PHASE-3; RISK; BCMA;
D O I：
10.1016/j.hoc.2023.05.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：1201 / 1214
页数：14
相关论文
共 50 条
  • [1] Cardiotoxicities of Chimeric Antigen Receptor T-Cell Therapy and Bispecific T-Cell Antibodies
    Qamer, Syed Zyad
    Miraglia, Genie M.
    Granville, Matthew J.
    Finkelstein, Alexa
    Okin, Emily
    Mahmood, Syed Saad
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2024, 26 (07) : 175 - 187
  • [2] Chimeric antigen receptor T-cell therapy
    Burge, Cale
    Vanguru, Vinay
    Ho, Phoebe Joy
    AUSTRALIAN PRESCRIBER, 2023, 46 (02) : 36 - 39
  • [3] Chimeric Antigen Receptor T-Cell Therapy
    Ogba, Ndiya
    Arwood, Nicole M.
    Bartlett, Nancy L.
    Bloom, Mara
    Brown, Patrick
    Brown, Christine
    Budde, Elizabeth Lihua
    Carlson, Robert
    Farnia, Stephanie
    Fry, Terry J.
    Garber, Morgan
    Gardner, Rebecca A.
    Gurschick, Lauren
    Kropf, Patricia
    Reitan, Jeff J.
    Sauter, Craig
    Shah, Bijal
    Shpall, Elizabeth J.
    Rosen, Steven T.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (09): : 1093 - 1106
  • [4] Chimeric Antigen Receptor T-Cell Therapy
    Rasheed, Azgar Abdul
    Koyyala, Venkata Pradeep Babu
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 89 - 92
  • [5] Redirection of T-cell effector functions for cancer therapy: bispecific antibodies and chimeric antigen receptors
    Satta, Alessandro
    Mezzanzanica, Delia
    Turatti, Fabio
    Canevari, Silvana
    Figini, Mariangela
    FUTURE ONCOLOGY, 2013, 9 (04) : 527 - 539
  • [6] Cardiotoxicities of Novel Therapies in Hematologic Malignancies: Chimeric Antigen Receptor T-Cell Therapy and Bispecific T-Cell Engager Therapy
    Marar, Rosalyn I. I.
    Abbasi, Muhannad Aboud
    Prathivadhi-Bhayankaram, Sruti
    Daryanani, Andres
    Villarraga, Hector
    Anavekar, Nandan
    Bhatt, Vijaya Raj
    Paludo, Jonas
    JCO ONCOLOGY PRACTICE, 2023, 19 (06) : 331 - +
  • [7] Progressive multifocal leukoencephalopathy in the era of chimeric antigen receptor T-cell therapy
    Mackenzie, Strachan
    Laurence, Arian
    O'Reilly, Maeve
    Peggs, Karl S.
    Roddie, Claire
    LANCET HAEMATOLOGY, 2021, 8 (12): : E870 - E873
  • [8] Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update
    Alsajjan, Roa
    Mason, Warren P.
    CURRENT ONCOLOGY, 2023, 30 (09) : 8501 - 8549
  • [9] Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma: Moving Into the Future
    Holstein, Sarah A.
    Grant, Shakira J.
    Wildes, Tanya M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (27) : 4416 - +
  • [10] Chimeric antigen receptor T-cell therapy for melanoma
    Razavi, Azadehsadat
    Keshavarz-Fathi, Mahsa
    Pawelek, John
    Rezaei, Nima
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (03) : 209 - 223
12345